Atrioventricular reentrant tachycardia

Articolo redatto e revisionato del Dott. Luca Moretti

Atrioventricular reentrant tachycardia, or AVRT, is an arrhythmia in which an accessory connection participates in a circuit linking the atria and ventricles. In the most common form, termed orthodromic, the impulse travels downward through the atrioventricular node and His-Purkinje system and returns upward along the accessory pathway. In the antidromic form, the abnormal connection conducts anterogradely toward the ventricle. The direction of travel produces different electrocardiographic features, but in both cases the tachycardia depends on the existence of an additional electrical connection.

AVRT can occur in people with evident preexcitation during sinus rhythm or with an apparently normal baseline ECG. A pathway that conducts only from the ventricles to the atria is concealed and can sustain episodes without a delta wave. For this reason, AVRT and Wolff-Parkinson-White syndrome are not synonymous. The former identifies the circuit of a tachycardia; the latter concerns preexcitation associated with clinical tachyarrhythmias and introduces a specific assessment of anterograde risk.

The mechanism is important in pediatric patients and young adults but can also be diagnosed later in life. The connections are generally congenital, whereas clinical onset depends on their properties, the nodal system, and triggering beats. Ablation can eliminate the responsible connection and provide a durable solution. The difficulty and risk of the procedure vary with location: a lateral pathway, a pathway close to His, and a connection associated with the coronary sinus require different anatomic reasoning.

Accessory pathway anatomy and construction of the circuit

The fibrous atrioventricular skeleton normally separates atrial from ventricular myocardium, leaving the nodal and His system as the physiologic connection. Atrioventricular accessory pathways are bridges of myocardial tissue that cross this separation and permit additional propagation. They may be located along the mitral or tricuspid annulus or in septal and paraseptal regions. Their course may be oblique, with atrial and ventricular insertions that are not directly opposite one another.

Common atrioventricular pathways have conduction properties more similar to working myocardium than to the AV node. Propagation is predominantly dependent on sodium currents and often does not show the progressive slowing typical of nodal tissue as rate increases. This difference has therapeutic and prognostic consequences. However, pathways with decremental conduction do exist: the property of slowing does not automatically demonstrate that every observed conduction event is occurring through the normal node.

The direction of conduction defines distinct clinical features. A bidirectional pathway can conduct from atrium to ventricle and vice versa; a retrograde-only pathway can sustain orthodromic AVRT but cannot directly preexcite the ventricles during atrial fibrillation. An exclusively anterograde pathway cannot by itself complete the retrograde limb of orthodromic AVRT but may participate in other circuits. Assessment should therefore describe what the connection actually conducts, not merely its anatomic presence.

When an anterograde pathway reaches the ventricle before the normal system, depolarization begins outside the His-Purkinje network. This produces a delta wave and fusion between accessory and normal activation. The degree of preexcitation depends on the time at which the impulse reaches the pathway, nodal conduction, and the insertion site. An anterograde pathway may be poorly visible if normal activation predominates: the terms latent or minimally manifest do not mean that a pathway is certainly incapable of anterograde conduction.

A concealed connection, in the electrophysiologic sense, conducts only retrogradely. Distinguishing it from an anterograde pathway masked by fusion is essential because the risk of preexcited atrial fibrillation concerns the ability to transmit impulses to the ventricles. A normal ECG at a single moment does not prove absence of that ability. Interrogation of the pathway with pacing and documentation of different tracings can clarify its behavior when this affects management.

The common orthodromic circuit includes the atrium, AV node, His system, ventricle, and retrograde accessory pathway. An appropriately timed atrial or ventricular premature beat can encounter unidirectional block in one component and allow reentry to begin. The final rate reflects the sum of conduction times and recovery properties along the pathway. It does not depend solely on the speed of the accessory pathway or on the degree of preexcitation observed during sinus rhythm.

Ventricular participation distinguishes classic AVRT from AVNRT. If the ventricle is an obligatory component, changing its activation can alter the return time to the atrium and the tachycardia cycle length. This principle underlies several diagnostic maneuvers, including the effect of ipsilateral bundle branch block on a lateral pathway. A change in QRS morphology is not merely cosmetic: it can lengthen the route needed to reach the ventricular insertion of the accessory pathway.

Multiple pathways can sustain different circuits in the same patient. Rarely, a tachycardia between two accessory pathways uses one connection anterogradely and another retrogradely without requiring the AV node as an indispensable component. Consequently, “AVRT” does not mean that every variant is guaranteed to terminate with AV nodal block. Precise reconstruction of the circuit is particularly important when the pharmacologic response does not match expectations.

Ebstein anomaly is an important association, in part because of the greater likelihood of multiple connections and altered tricuspid annular anatomy. Other congenital heart diseases or previous procedures may modify access and signals. An accessory pathway can also coexist with AVNRT, atrial tachycardia, or fibrillation. Identifying it does not prove that it is responsible for every arrhythmia in the patient: a component of the circuit must be distinguished from a bystander connection.

Nodofascicular, nodoventricular, and fasciculoventricular connections are not simply interchangeable variants of common atrioventricular pathways. Some can participate in complex circuits, whereas an isolated fasciculoventricular pathway is generally a bystander connection that does not sustain common atrioventricular reentry. Incorrectly assigning it a causal role can lead to unnecessary ablation near the normal conduction system. Mahaim pathways require dedicated characterization of their location and decremental conduction.

Orthodromic and antidromic forms, symptoms, and clinical risk

Orthodromic AVRT is the most frequent presentation of reentry mediated by an accessory pathway. Ventricular depolarization proceeds through the normal conduction system, so the QRS is usually narrow and preexcitation may be absent during tachycardia even when the sinus-rhythm ECG shows a delta wave. The atrium is activated retrogradely after the ventricle, with a P wave often recognizable in the ST segment. Pathway location and nodal timing influence P-wave morphology and the RP interval.

Antidromic AVRT, by contrast, produces preexcited anterograde activation and a wide QRS. Return can occur through the normal system or, in selected circuits, through another pathway. On the surface ECG it may be difficult to distinguish from ventricular tachycardia or an atrial arrhythmia conducted through a bystander accessory pathway. Known preexcitation makes the mechanism plausible but does not prove it automatically and does not eliminate the ventricular differential diagnosis.

PJRT is a particular orthodromic AVRT sustained by a slowly conducting, decremental retrograde pathway, often posteroseptal. It can present with a long RP interval and an incessant or highly recurrent course. The historical name does not indicate that the generator is an automatic junctional focus. Rhythm persistence makes cardiomyopathy risk relevant even when the rate is not extreme and palpitations are only mildly perceived.

A typical orthodromic episode presents as sudden regular palpitations, sometimes after a premature beat. Dyspnea, chest discomfort, weakness, and dizziness depend on the hemodynamic response. Abrupt onset and termination suggest a circuit but do not distinguish AVRT from AVNRT. An accurate description of symptoms is useful for choosing the recording strategy and comparing different episodes; it does not replace the electrical documentation needed to identify the pathway.

Tolerance is determined by rate, duration, filling, and cardiac reserve. Retrograde atrial contraction may occur at an unfavorable phase and contribute to neck pulsations or discomfort. In patients with heart disease, even a moderate reduction in diastolic time may cause congestion or ischemia. Initial stability does not guarantee that a prolonged episode will remain well tolerated, and the subjective intensity of palpitations does not reliably measure cardiac output.

In infants, tachycardia may be recognized because of feeding difficulty, pallor, irritability, sweating, or heart failure. The absence of a report of palpitations does not reduce the potential severity. The pediatric presentation requires age-adjusted rate interpretation and dosing, as well as consideration of body weight in invasive decisions. Some early arrhythmias change in frequency over time, but clinical improvement should not be equated without verification with anatomic disappearance of the pathway.

The risk of an AVRT episode and that of preexcited atrial fibrillation are related but distinct. AVRT can facilitate initiation of fibrillation; if rapid anterograde conduction exists over the pathway, many impulses can reach the ventricles without nodal filtering. Ventricular degeneration is the most feared specific risk. A truly retrograde-only pathway does not produce this preexcitation mechanism, although it can sustain symptomatic tachycardias.

The frequency of episodes does not directly describe the pathway's anterograde refractoriness. Rare or well-tolerated orthodromic episodes do not exclude a potentially rapid connection during fibrillation. When preexcitation or suspicious features are present, assessment includes pathway properties, any multiple connections, and the individual's context. Evaluation of WPW syndrome therefore retains its own purpose, while treatment of AVRT also focuses on eliminating the symptomatic circuit.

Syncope during a documented tachycardia may reflect hypoperfusion, but undocumented loss of consciousness in a patient with preexcitation requires particular attention. Episodes during exercise, prodromal symptoms, timing within the episode, and a possible pause after termination should be distinguished. Reflex causes or other arrhythmias may also coexist. The presence of a pathway should not become an automatic explanation for every event, but neither should it be ignored when the context suggests arrhythmic risk.

Pregnancy, sports participation, and safety-sensitive occupations modify the practical significance of recurrence. A tachycardia without consequences at rest may be incompatible with safely controlling a vehicle or performing particular activities. Individual assessment should integrate pathway risk, episode characteristics, and the consequences of a possible event. Ablation may be motivated by prevention of recurrence or by anterograde safety, two goals that should be explained separately to the patient.

ECG, documentation of episodes, and differential diagnosis

The ECG during orthodromic AVRT usually shows a regular narrow-QRS rhythm with subsequent retrograde atrial activation. The P wave may be more separated from the QRS than in common typical AVNRT, but there is overlap, especially with septal pathways. Interpretation considers all leads because a subtle atrial deflection in one location may be recognizable elsewhere. A definitive diagnosis should not be based on a single RP measurement when the P wave is uncertain.

Retrograde P-wave morphology provides clues about the atrial activation sequence but does not localize a pathway with sufficient precision for ablation. A left-sided and a septal pathway can produce different orientations, also influenced by anatomy and signal fusion. Morphology should be integrated with timing and intracardiac recordings. A negative P wave in the inferior leads does not automatically indicate a posteroseptal pathway because other tachycardias can produce the same finding.

QRS alternans may be observed during rapid AVRT but is not an exclusive criterion. Variations in ventricular conduction and other tachycardias can also generate alternans. The finding has meaning within the context of regularity, atrioventricular relationship, and comparison with baseline rhythm. Turning it into an absolute diagnostic rule can lead to false localization of the circuit.

The appearance of ipsilateral bundle branch block on the side of a lateral pathway can lengthen the route from the His system to the ventricular insertion of the connection, increasing the VA interval and sometimes the tachycardia cycle length. When documented under appropriate conditions, this phenomenon supports participation of the pathway in the circuit. Absence of slowing does not exclude AVRT, especially for septal pathways or when nodal conduction compensates. The relevant interval changes matter, not merely the difference in overall rate.

Between episodes, manifest preexcitation is recognized by integrating the PR interval, delta wave, and QRS morphology. A short PR alone does not demonstrate WPW, and a QRS that is not very wide does not exclude minimal preexcitation. Delta-wave polarity can suggest a region of the annulus and assist planning, but localization algorithms have limitations with minimal fusion, multiple pathways, and congenital anatomies. The definitive target is established by mapping.

Intermittent loss of preexcitation may result from pathway block, but a gradual QRS change can also reflect increasing predominance of nodal conduction. Sudden and complete loss during observation or exercise provides different information from simple reduction of the delta wave. None of these findings alone guarantees zero risk. If the result changes an important decision, specialist evaluation should clarify which phenomenon was actually observed.

A normal sinus-rhythm ECG still permits a concealed pathway. Diagnosis emerges from the tachycardia or from retrograde conduction during electrophysiologic study. It is useful to retrieve older tracings because a pathway that is minimally manifest on one occasion may be evident on another. The distinction between observed absence of preexcitation and demonstrated inability to conduct anterogradely should be preserved in the clinical description, particularly when discussing medications and the risk of preexcited fibrillation.

Antidromic AVRT is part of the differential diagnosis of regular wide-complex tachycardias together with ventricular tachycardia, supraventricular tachycardia with aberrancy, and a preexcited atrial arrhythmia. The presence of a sinus delta wave or previous AVRT does not eliminate the alternatives. If the rhythm is undefined, management should preserve a margin of safety for a possible ventricular origin. Blood-pressure stability and young age are not sufficient criteria to exclude it.

An irregular wide-complex tachycardia with varying morphologies should raise concern for preexcited atrial fibrillation, especially if the rate is very high. It is not simply an irregular version of orthodromic AVRT and requires a different therapeutic pathway. Flutter or atrial tachycardia may also be conducted over the pathway as a bystander. Preexcitation describes how the ventricles are activated but does not by itself identify the atrial generator or responsible circuit.

The response to vagal maneuvers and adenosine can terminate common orthodromic AVRT because the AV node is essential to anterograde conduction. The same behavior is seen in AVNRT, so conversion does not distinguish the two. If atrial activity continues during ventricular block, an independent atrial arrhythmia should be considered. It is essential to record the entire response and verify that a new preexcited rhythm does not appear rather than interpreting only the temporary return to a lower rate.

Ambulatory monitoring should have a duration consistent with episode frequency. A patient-activated ECG can document abrupt onset and regularity, but a single lead often does not define the pathway. Clinical review of the original signal remains necessary. Echocardiography looks for congenital heart disease, valvular disease, and dysfunction, while blood tests are adapted to precipitating factors and treatment safety.

Exercise testing can assist with exercise-related symptoms and noninvasive assessment of preexcitation but does not replace every other form of risk stratification. Genetic testing or advanced imaging is reserved for suggestive phenotypes, such as hypertrophy associated with preexcitation, conduction disorders, or familial disease. The aim is to define the relevant circuit and substrate rather than indiscriminately applying every test to each person with documented AVRT.

Electrophysiologic study, pathway participation, and mapping

The electrophysiologic study should answer distinct questions: whether an accessory connection exists, in which directions it conducts, where it inserts, and whether it is necessary for the tachycardia. A pathway may be present without participating in the observed circuit. Demonstrating extranodal conduction alone is therefore insufficient to classify every induced tachycardia as AVRT. Clinical documentation guides comparison between arrhythmias reproduced in the laboratory and spontaneous symptoms.

During sinus rhythm or atrial pacing, an anterograde pathway can produce early ventricular activation and a short or negative HV interval, depending on the relationship between His activation and local depolarization. Increased preexcitation during pacing can make the pathway contribution more evident. The measurement should be interpreted together with the QRS and activation sequence because not every form of short HV corresponds to a common atrioventricular connection with the same risk or ablation indication.

Ventricular pacing explores the return pathway to the atria. A left lateral pathway may produce early atrial activation in the distal coronary sinus, whereas a septal pathway may produce a concentric sequence similar to nodal conduction. Nondecremental retrograde conduction supports suspicion of a common accessory pathway, but exceptions prevent an absolute rule. Eccentricity alone is also insufficient because AVNRT can have variable atrial exit points.

A His-refractory ventricular extrastimulus can reach the atrium through an extranodal connection while the normal pathway is refractory. If it advances the atrium, it demonstrates an alternative retrograde access route in the appropriate technical context; if it changes the tachycardia coherently, it strengthens evidence of participation. A bystander pathway may advance the atrium without altering a nodal or atrial generator. The relationship between atrial modification and the next cycle is therefore essential.

Termination without atrial activation after an appropriately timed ventricular stimulus is particularly strong evidence for a circuit dependent on the retrograde pathway. Capture, stimulus timing, and the possibility of atypical connections must nevertheless be verified. Absence of a response does not exclude the pathway: the stimulus may not have reached the insertion at the useful time or the tissue may have been refractory. The power of the maneuver depends on its conditions, not on merely delivering an extrastimulus.

Ventricular entrainment temporarily drives the tachycardia at an imposed rate and permits analysis of the return sequence. A V-A-V response after pacing cessation is consistent with AVRT or AVNRT, whereas an A-A-V sequence may favor atrial tachycardia. The last captured atrium, anterograde conduction, and possible double responses must be recognized. Without this verification, the apparent sequence may be misclassified.

The difference between the post-pacing interval and tachycardia cycle length helps compare the pacing site with the circuit location. A short return from the ventricle, after correction for conduction changes when necessary, favors accessible AVRT over AVNRT. Published thresholds are not universal: ventricular pacing site, distance from the pathway, decremental conduction, and nodal slowing influence the result. Comparison with the stimulus-to-atrial interval and other maneuvers makes interpretation more reliable.

Para-Hisian pacing evaluates retrograde conduction by changing direct capture of His or the conduction system while maintaining local ventricular capture. A response compatible with extranodal access can support a septal pathway. Direct atrial capture must be excluded, and the type of capture at each output must be documented. Distant or decremental pathways and unusual anatomies can make the response less straightforward than the teaching model.

Once participation has been established, anterograde mapping seeks the earliest ventricular activation during pathway conduction; retrograde mapping identifies the earliest atrium during ventricular pacing or tachycardia. A-V and V-A relationships, any recognizable accessory potentials, and unipolar signals are examined together with anatomic position. No single signal replaces the combined assessment of prematurity, consistency, and contact stability.

An oblique course may cause the site with earliest atrial activation not to coincide with that of initial ventricular activation. Pacing from different sites changes the sequence and can separate potentials that were previously fused. This analysis helps distinguish insertions, identify multiple connections, and select the most accessible and safe point. The actual electrical pathway is more informative than location predicted solely by an ECG algorithm.

Mechanical block of the pathway caused by the catheter can abruptly abolish preexcitation or retrograde conduction. The phenomenon provides a clue to proximity but does not prove a durable lesion and may temporarily prevent further mapping. The position should be preserved and the subsequent course observed, avoiding declaration of success before stability of the block has been verified. Return after transient trauma is not equivalent to a new circuit.

If the pathway conducts anterogradely, the study can assess refractoriness and preexcited intervals during induced fibrillation when appropriate. An anterograde effective refractory period no greater than 250 ms or a shortest preexcited RR interval no greater than 250 ms are risk markers in the context of guideline recommendations. Autonomic conditions, drugs, and protocol influence the measurements. These parameters address the risk of rapid conduction during fibrillation, a different question from demonstration of the symptomatic orthodromic circuit.

The final report should describe location, direction, pathway properties, the documented circuit, and any other arrhythmias. A low-risk bystander pathway may not require the same treatment as a connection responsible for recurrent AVRT, whereas a high-risk anterograde pathway may warrant treatment even if it does not sustain the initially observed tachycardia. Separating the two indications allows a coherent decision and understandable informed consent.

Treatment of the acute episode and ablation of accessory connections

Acute treatment depends on the rhythm present and hemodynamic stability, not merely on the historical diagnosis of an accessory pathway. If tachycardia causes hemodynamic compromise, synchronized cardioversion provides rapid rhythm restoration and should not be delayed while seeking precise localization. When the patient is stable, distinguishing narrow orthodromic AVRT, wide antidromic AVRT, and preexcited fibrillation determines which drugs are appropriate.

In regular narrow-QRS orthodromic AVRT, vagal maneuvers can interrupt the anterograde nodal component. If they fail, intravenous adenosine is a reference option in a monitored setting, with suitable venous access and cardioversion immediately available. The presence of sinus-rhythm preexcitation does not make this situation identical to preexcited fibrillation. It remains necessary, however, to watch for induction of fibrillation and immediately recognize any rhythm change.

Adenosine requires a rapid bolus and immediate line flush; doses and titration follow the clinical protocol and patient characteristics. Bronchospasm, sinus-node disease, and conduction disorders without adequate pacing support may limit its use. The tracing should be retained to distinguish circuit termination, simple AV nodal block, and recurrence from a new trigger. A transient response should not be described generically as failure without examining the sequence.

Verapamil, diltiazem, or beta-blockers can be considered in clearly defined orthodromic tachycardia in selected patients, taking into account blood pressure, ventricular function, and preexcitation. They are not an indiscriminate choice for every rapid rhythm in a person with an accessory pathway. Pharmacologic stacking increases the risk of hypotension and block, especially if the patient has already taken medication during the episode. When diagnosis or tolerance becomes uncertain, the strategy should be changed rather than doses accumulated.

In antidromic tachycardia, anterograde conduction over the accessory pathway makes drugs acting on the pathway relevant, but the differential diagnosis from ventricular tachycardia must be sufficiently secure. Procainamide or other selected antiarrhythmics may be used according to availability, structural heart disease, QT interval, and local expertise. A circuit between two pathways does not necessarily depend on the AV node. In case of doubt or clinical deterioration, cardioversion avoids reliance on an unverified pharmacologic hypothesis.

Preexcited atrial fibrillation requires a specific pathway: cardioversion in the presence of instability and, in selected stable patients, options such as procainamide or ibutilide according to contraindications and availability. Adenosine, beta-blockers, verapamil, diltiazem, and digoxin are inappropriate because AV nodal blockade can favor a dangerous ventricular response over the pathway. Intravenous amiodarone should also be avoided in this setting. This is not merely a dosing exception but a different relationship between the atrial generator and ventricular conduction.

For prevention, a concealed pathway causing infrequent, well-tolerated AVRT raises a different problem from a rapidly conducting anterograde connection. AV nodal drugs can be considered when ablation is not chosen and there is no relevant preexcitation. Class Ic drugs may have a selected role in the absence of structural or ischemic heart disease under specialist supervision. The strategy should be based on demonstrated pathway properties, not on a single ECG without a delta wave.

Accessory pathway ablation is recommended for symptomatic recurrent AVRT and offers a high probability of a durable cure. It may also be indicated because of high-risk anterograde properties, regardless of episode frequency. The procedure targets the accessory bridge while preserving the normal nodal system. The indication should be distinguished from AV nodal ablation, which is a different procedure and is not the standard treatment for AVRT.

For left-sided pathways, access may be transseptal to the left atrium or retrograde aortic to the ventricular aspect of the mitral annulus. The choice depends on pathway location, anatomy, age, and center expertise. Arterial access, valve crossing, and entry into left-sided chambers carry specific risks and procedural anticoagulation requirements. There is no universally better access route independent of the connection being treated.

Right free-wall pathways may be challenging because of contact stability on the tricuspid annulus. Navigation support and three-dimensional mapping can improve orientation and reduce radiation exposure. Difficulty does not necessarily imply a more dangerous substrate but can increase the risk of ineffective lesions and recurrence of conduction. Distinguishing a localization problem from a contact problem is useful before increasing the extent of applications.

With septal or para-Hisian pathways, proximity to the normal conduction system makes the risk of atrioventricular block a priority. The possibility of targeting an insertion farther from His, choosing an alternative approach, or using cryoenergy is assessed. The map should clearly identify conduction-system potentials. A high overall probability of ablation success does not remove the need to discuss the specific risk of a delicate location and, in some cases, to accept a more cautious approach.

Posteroseptal or epicardial connections may be associated with the coronary sinus, its branches, or diverticula. At these sites, venous wall anatomy and proximity to coronary arteries make energy delivery different from that at a common endocardial surface. Coronary relationships may need to be defined by imaging or angiography and the energy and strategy adjusted. Standard powers and durations should not automatically be transferred to a venous site with adjacent vascular structures.

Acute elimination of accessory conduction should be verified in the directions that were originally present. Disappearance of the delta wave is useful for an anterograde pathway but does not prove absence of residual retrograde conduction or of a second connection. Pacing, an observation period, and selected pharmacologic testing help distinguish durable block from transient suppression. Noninducibility of AVRT completes the assessment together with verification of physiologic conduction.

The probability of success is high and exceeds 95% in many reported experiences, but location and complexity modify the individual result. Multiple pathways, an oblique course, epicardial location, and congenital anatomy may require additional strategies or another procedure. Consent should describe these factors rather than presenting percentages as guarantees. A safe, documented result is preferable to extending lesions without a convincing target.

In young children, pregnancy, and congenital heart disease, the indication and technique are adapted to the context. Ablation before pregnancy can be discussed when known recurrent AVRT is present; during pregnancy, a necessary procedure requires expertise and minimization of exposure. In small children, body weight, vascular access, and the likelihood of controlling the arrhythmia with drugs influence the timing of intervention. Adult doses and outcomes from ordinary anatomies cannot be transferred directly.

Prognosis, complications, and follow-up after pathway elimination

After effective ablation of the responsible connection, prognosis is favorable in most patients. Elimination of the circuit reduces episodes and the need for prophylaxis, while treatment of an anterograde pathway can also remove the dangerous route for preexcited fibrillation. This result should be documented and distinguished from persistence of other arrhythmias or structural heart disease. Success on the pathway is not equivalent to correction of every possible electrical abnormality of the heart.

Recurrence of conduction may manifest as reappearance of the delta wave, return of AVRT, or evidence of retrograde conduction. The three phenomena do not always occur together. A pathway that recovers only retrograde conduction can sustain tachycardia without evident preexcitation; anterograde recurrence may be asymptomatic. Follow-up should therefore be guided by the original pathway properties and procedural goals, not only by the presence of palpitations.

Recovery of conduction may result from an incomplete lesion, a transient thermal effect, or difficulty maintaining contact. A second pathway not recognized initially may become more evident after elimination of the first and produce an apparently new picture. Review of the previous signals and localization helps distinguish these possibilities. A new procedure should be designed on the basis of this analysis, not as an undifferentiated repetition of the same applications.

Atrial fibrillation may persist even after pathway ablation, especially when an independent atrial substrate exists. Eliminating the accessory connection prevents preexcited conduction through that pathway but does not guarantee disappearance of the atrial generator. Any anticoagulation is decided according to the atrial diagnosis and the patient's risk. Isolated AVRT, by contrast, is not automatically an indication for chronic anticoagulant therapy.

In incessant forms, arrhythmia control can permit substantial ventricular recovery. Its extent and time course should be documented by clinical and echocardiographic follow-up. Preexisting cardiomyopathy may coexist and limit recovery, while a new recurrence can cause deterioration. Heart-failure therapies are therefore reassessed according to function and the overall picture rather than solely on immediate cessation of tachycardia.

An anterograde pathway can also contribute to ventricular dyssynchrony through abnormal activation, particularly at some sites and in pediatric populations. Dysfunction should not always be attributed solely to the rate of tachycardia episodes. If preexcitation significantly alters the ventricular activation sequence, improvement after pathway elimination may also reflect restored synchrony. A causal relationship requires specialist assessment and comparison of functional data before and after treatment.

Procedural complications include bleeding and vascular injury, pericardial effusion, and, depending on the access route, thromboembolic or valvular risks. Atrioventricular block is particularly relevant at sites close to the AV node and His; coronary injury must be considered for applications near coronary arteries or within the coronary venous system. The overall rarity of these events does not make assessment of site-specific anatomic relationships unnecessary.

After discharge, significant chest pain, dyspnea, syncope, or an enlarging hematoma requires prompt evaluation. Instructions on resuming activities depend on vascular access and local evolution, while any prescribed antithrombotic therapy follows the type of procedure and other clinical indications. It should not automatically be treated as chronic therapy for AVRT. The patient should know which drugs to continue, why they are being taken, and when they should be reviewed.

Residual palpitations may be caused by premature beats that previously initiated the circuit but now no longer encounter a reentrant pathway. A brief sensation does not prove failure, but sustained episodes with the original characteristics should be recorded. A monitor selected according to symptom frequency can distinguish recurrence of accessory conduction, concomitant AVNRT, atrial tachycardia, and sinus accelerations. This distinction avoids both unnecessary alarm and undocumented reassurance.

In athletes and occupations in which an event could have serious consequences, return to activity requires an assessment consistent with the initial risk, procedural outcome, and applicable requirements. Subjective absence of episodes does not replace verification required for a pathway that was previously high risk. Documentation that conduction has been eliminated and of any residual arrhythmia allows more robust and understandable decisions.

Useful follow-up preserves the ECG before and after ablation, the location and conduction directions of the pathway, the maneuvers that demonstrated its participation, the access route used, and the final result. Continuity of documentation is particularly important for concealed pathways, for which a normal baseline ECG does not reveal the mechanism, and for children who will transition to adult services. If new symptoms occur, these data allow the current picture to be compared with the original one and the investigations actually needed to be selected.